
Should You Get Genetic Testing for Pancreatic Cancer?
Genetic testing for pancreatic cancer isn't just for patients—NCCN urges it for all who are diagnosed, and carriers may start screening years earlier.

Genetic testing for pancreatic cancer isn't just for patients—NCCN urges it for all who are diagnosed, and carriers may start screening years earlier.

Hereditary pancreatic cancer is behind about 1 in 10 cases. Knowing which genes—BRCA2, CDKN2A—raise risk helps you and your family decide on testing.

What causes pancreatic cancer is rarely one thing — but smoking accounts for about 1 in 4 cases, and the biggest risks are often ones you can change.

Pancreatic cancer pain often needs more than pills. A celiac plexus block can ease it — but it won't extend survival. Here's what each option really does.

Pancreatic cancer can block the gut two ways—at the stomach's outlet or lower in the bowel. Know the signs, the red flags, and what eases it.

Pancreatic cancer blood clots affect about 1 in 5 patients—the highest rate of any cancer. Here's why they happen, the warning signs, and when to act.

Pancreatic cancer clinical trials increasingly target KRAS — found in over 90% of tumors — so biomarker testing can open doors to new studies.

A pancreatic cancer mRNA vaccine is showing early promise in trials, but it is not yet approved. Here is what the research shows — and doesn't.

KRAS pancreatic cancer treatment just reached a turning point: drugs targeting the gene behind 90% of these tumors are now showing real benefit in trials.

Pancreatic cancer chemo side effects vary by regimen—and fatigue affects over 80% of people on chemo. Here's what's common, what's serious, and what helps.